Keyphrases
CAR T-cell Therapy
100%
Repolarization
100%
Tumor-associated Myeloid Cells
100%
Solid Tumors
80%
Chimeric Antigen Receptor T Cells (CAR-T)
80%
Toll-like Receptor 7 (TLR7)
80%
Tumor-associated Macrophages
60%
Myeloid-derived Suppressor Cells
60%
Pro-inflammatory Phenotype
40%
In Cancer
20%
Toll-like
20%
Immune System
20%
Weight Loss
20%
Myeloid Cells
20%
Immunosuppressive Tumor
20%
Immune Cells
20%
Folate Targeting
20%
Cellular Accumulation
20%
Healthy Tissue
20%
Hematopoietic Cancer
20%
Immune-competent
20%
Regress
20%
Cell Penetration
20%
Inflammatory Phenotype
20%
M1-like
20%
M2-like
20%
Immunosuppressive Microenvironment
20%
Immunosuppressive Myeloid Cells
20%
Cancer Cell Heterogeneity
20%
Solid Tumor Microenvironment
20%
Endogenous T Cells
20%
Medicine and Dentistry
Solid Malignant Neoplasm
100%
Neoplasm
100%
CAR T-cell therapy
100%
Myeloid Cell
100%
Repolarization
100%
Toll Like Receptor 7
100%
Chimeric Antigen Receptor T-Cell
80%
Immunosuppressive Drug
80%
Macrophage
60%
Myeloid-Derived Suppressor Cell
60%
Cancer
20%
T Cell
20%
Immune System
20%
Cancer Cell
20%
Immunity
20%
Anti-Inflammatory Drug
20%
Folic Acid
20%
Immunocompetent Cell
20%
Cell Heterogeneity
20%
Immunology and Microbiology
Myeloid
100%
Chimeric Antigen Receptor T-Cell
100%
Repolarization
100%
Immunosuppressive Drug
44%
TLR7
44%
Tumor-Associated Macrophage
33%
Myeloid-Derived Suppressor Cell
33%
Toll-Like Receptor
11%
Agonist
11%
T Cell
11%
Cancer Cell
11%
Immunity
11%
Immunocompetent Cell
11%
Immune System
11%
Cell Heterogeneity
11%